A white paper published last year by IQVIA, Alexion and AstraZeneca considers how the Innovative Medicines Fund can transition from the Cancer Drugs Fund and question how the fund can be effective in its goal of getting promising treatments to patients.
For Rare Disease Day, Head of Paediatrics at the University of Cambridge, Professor David Rowitch discusses recent research findings.
Scotland’s legal Covid-19 restrictions will end on 21 March.
Boris Johnson today announced his long-term strategy for living with the Covid virus.
Kim Leadbeater MP recently sat down with Chamber to talk about the issue of loneliness. Read here about how we can build a more connected society after the pandemic.
A major review into ethnic inequalities in healthcare has revealed significant inequalities across a range of health services. Conducted by the NHS Race & Health
The Prime Minister set an ambitious target to make the UK a “life science superpower” and Curia’s NHS Life Sciences Commission will scope ways to
As a new generation of older LGBT+ people look into arrangements for supported living, there needs will need to be accounted for.
Today Prime Minister announced to Parliament that all remaining Covid restrictions in England – including the legal rule to self-isolate – could end later this
A Paralysed man with severed spine walks thanks to implant, as researchers have created human spinal cord implants in a world first.
Plans to tackle the backlog of patients on hospital waiting lists in England have been delayed following intervention by the Treasury.
In the third of a series of features, leading experts in the healthcare and life science sectors joined the Science Minister and the Mayor of Cambridgeshire and Peterborough at a question-time debate panel discussion in Cambridge.
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.